• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Evaluation of new nanotechnology to raise HDL cholesterol level and elucidation of its molecular mechanism

Research Project

Project/Area Number 23659463
Research Category

Grant-in-Aid for Challenging Exploratory Research

Allocation TypeMulti-year Fund
Research Field Metabolomics
Research InstitutionUniversity of Tsukuba

Principal Investigator

SHIMANO Hitoshi  筑波大学, 医学医療系, 教授 (20251241)

Co-Investigator(Kenkyū-buntansha) TAKAHASHI Akimitsu  筑波大学, 医学医療系, 准教授 (70344893)
MATSUZAKA Takashi  筑波大学, 医学医療系, 准教授 (70400679)
Project Period (FY) 2011
Project Status Completed (Fiscal Year 2011)
Budget Amount *help
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2011: ¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Keywordsリポタンパク質 / 動脈硬化 / 胆汁酸 / ナノテクノロジー / 脂質異常症
Research Abstract

Raising HDL-cholesterol (C) has emerged as a potential strategy to tackle the residual risk that remains even after lowering LDL-C and triglyceride, in preventing cardiovascular disease. PEGylated and quaternized polyamine nanogel (Q-Nanogel) is a newly synthesized bile salt sequestering agent intended to treat dyslipidemia. We assessed the effects of Nanogel on dyslipidemia and atherosclerosis. Nanogel treatment resulted in a 35% reduction in plasma VLDL/LDL-C levels, a 58% increase in plasma HDL-C levels in C57BL/6J mice. In LDLR-/-mice, atherosclerotic lesion size with Nanogel was reduced by 45% compared to PBS. These data indicate that Nanogel not only decreased VLDL/LDL-C levels but also raised HDL-C levels. Nanogel could be a potential therapeutic candidate to raise HDL-C and the treatment of atherosclerosis.

Report

(2 results)
  • 2011 Annual Research Report   Final Research Report ( PDF )
  • Research Products

    (26 results)

All 2012 2011 Other

All Journal Article (13 results) (of which Peer Reviewed: 13 results) Presentation (10 results) Remarks (2 results) Patent(Industrial Property Rights) (1 results)

  • [Journal Article] TFE3 regulates muscle metabolic gene expression, increases glycogen stores, and enhances insulin sensitivity in mice2012

    • Author(s)
      Iwasaki H, Naka A, Iida KT, Nakagawa Y, Matsuzaka T, Ishii KA, Kobayashi K, Takahashi A, Yatoh S, Yahagi N, Sone H, Suzuki H, Yamada N, Shimano H.
    • Journal Title

      Am J Physiol Endocrinol Metab

      Volume: 302(7) Pages: 896-902

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Novel qualitative aspects of tissue fatty acids related to metabolic regulation : Lessons from Elovl6 knockout2012

    • Author(s)
      Shimano H
    • Journal Title

      Prog Lipid Res

      Volume: (in press)

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] TFE3 regulates muscle metabolic gene expression, increases glycogen stores, and enhances insulin sensitivity in mice2012

    • Author(s)
      Iwasaki H, Naka A, Matsuzaka T, Shimano H, et al
    • Journal Title

      Am J Physiol Endocrinol Metab

      Volume: 302(7)

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Novel qualitative aspects of tissue fatty acids related to metabolic regulation : Lessons from Elvol6 knockout2012

    • Author(s)
      Shimano H
    • Journal Title

      Prog Lipid Res

      Volume: (in press)

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Suppression of the pancreatic duodenal homeodomain transcription factor-1 (Pdx-1) promoter by sterol regulatory element-binding protein-1c (SREBP-1c)2012

    • Author(s)
      Amemiya-Kudo M, Yamada N, Murase T, Shimano H, et al
    • Journal Title

      J Biol Chem

      Volume: 286(32) Pages: 27902-14

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Macrophage Elovl6 deficiency ameliorates foam cell formation and reduces atherosclerosis in low-density lipoprotein receptor-deficient mice2011

    • Author(s)
      Saito R, Matsuzaka T, Karasawa T, Sekiya M, Okada N, Igarashi M, Matsumori R, Ishii K,Nakagawa Y, Iwasaki H, Kobayashi K, YatohS, Takahashi A, Sone H, Suzuki H, Yahagi N,Yamada N, Shimano H
    • Journal Title

      Arterioscler Thromb Vasc Biol

      Volume: 31(9) Pages: 1973-9

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Inhibition of ubiquitin ligase F-box and WD repeat domain-containing 7α (Fbw7α) causes hepatosteatosis through Kruppel-like factor 5(KLF5)/peroxisome proliferator-activatedreceptor γ2 (PPARγ2) pathway but not SREBP-1c protein in mice2011

    • Author(s)
      Kumadaki S, Karasawa T, Matsuzaka T, EmaM, Nakagawa Y, Nakakuki M, Saito R,Yahagi N, Iwasaki H, Sone H, Takekoshi K,Yatoh S, Kobayashi K, Takahashi A, SuzukiH, Takahashi S, Yamada N, Shimano H
    • Journal Title

      J Biol Chem

      Volume: 286(47) Pages: 40835-46

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Sterol regulatory element-binding protein-1 determines plasma remnant lipoproteins and accelerates atherosclerosis in low-density lipoprotein receptor-deficient mice.2011

    • Author(s)
      Karasawa T, Takahashi A, Saito R, Sekiya M,Igarashi M, Iwasaki H, Miyahara S,Koyasu S, Nakagawa Y, Ishii K, Matsuzaka T, Kobayashi K, Yahagi N, Takekoshi K, Sone H, Yatoh S, Suzuki H, Yamada N,S himano H
    • Journal Title

      Arterioscler Thromb Vasc Biol

      Volume: 31(8) Pages: 1788-95

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Suppression of the pancreatic duodenal homeodomain transcription factor-1 (Pdx-1) promoter by sterol regulatory element-binding protein-1c (SREBP-1c)2011

    • Author(s)
      Amemiya-Kudo M, Oka J, Takeuchi Y, Okazaki H, Yamamoto T, Yahagi N, Matsuzaka K, Okazaki S, Osuga J, Yamada N, Murase T, Shimano H
    • Journal Title

      J Biol Chem

      Volume: 286(32) Pages: 27902-14

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Inhibition of ubiquitin ligase F-box and WD repeat domain-containing 7α (Fbw7α) causes hepatosteatosis through Kruppel-like factor 5 (KLF5)/peroxisome proliferator-activated receptor γ2 (PPARγ2) pathway but not SREBP-1c protein in mice2011

    • Author(s)
      Kumadaki S, Matsuzaka T, Yamada N, Shimano H, et al
    • Journal Title

      J Biol Chem

      Volume: 286(47) Pages: 40835-46

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Macrophage Elovl6 deficiency ameliorates foam cell formation and reduces atherosclerosis in low-density liporotein receptor-deficient mice2011

    • Author(s)
      Saito R, Matsuzaka T, Yamada N, Shimano H, et al
    • Journal Title

      Arterioscle Thromb Vasc Biol

      Volume: 31(9) Pages: 1973-9

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] HbA1c 5.7-6.4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3) : a longitudinal cohort study2011

    • Author(s)
      Heianza Y, Shimano H, Yamada N, Sone H, et al
    • Journal Title

      Lancet

      Volume: 378(9786) Pages: 147-55

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Sterol regulatory element-binding protein-1 determines plasma remnant lipoproteins and accelerates atherosclerosis in low-density lipoprotein receptor-deficient mice2011

    • Author(s)
      Karasawa T, Matsuzaka T, Yamada N, Shimano H, et al
    • Journal Title

      Arterioscler Thromb Vasc Biol

      Volume: 31(8) Pages: 1788-95

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Presentation] "PEGylated and quaternized polyamine nanogel", a brand-new bile acid sequestrant, ameliorates lipoprotein profiles and reduces atherosclerosis in low-density-lipoprotein receptor deficient and apolipoprotein E deficient mice2012

    • Author(s)
      Rie Matsumori, Takashi Matsuzaka, Yukio Nagasaki, Hitoshi Shimano, et al
    • Organizer
      第76回日本循環器病学会
    • Place of Presentation
      福岡国際会議場(福岡市)
    • Year and Date
      2012-03-17
    • Related Report
      2011 Annual Research Report
  • [Presentation] A novel bile salt sequestering agent_PEGylated and quaternized polyamine nanogel reduces VLDL and LDL cholesterol, raises HDL cholesterol, and prevents atherosclerosis in mice2011

    • Author(s)
      Rie Matsumori, Takashi Matsuzaka, Yukio Nagasaki, Hitoshi Shimano, et al
    • Organizer
      第84回米国心臓協会学術集会(AHA Scientific Sessions2011)
    • Place of Presentation
      Orange Country Convention Center, Orlando, Florida,USA
    • Year and Date
      2011-11-15
    • Related Report
      2011 Final Research Report
  • [Presentation] A novel bile salt sequestering agent "PEGylated and quaternized polyamine nanogel" reduces YLDL and LDL cholesterol, raises HDL cholesterol, and prevents atherosclerosis in mice2011

    • Author(s)
      Rie Matsumori, Takashi Matsuzaka, Yukio Nagasaki, Hitoshi Shimano, et al
    • Organizer
      第84回米国心臓協会学術集会(AHA Scientific Sessions 2011)
    • Place of Presentation
      アメリカ(フロリダ)
    • Year and Date
      2011-11-15
    • Related Report
      2011 Annual Research Report
  • [Presentation] PEGylated and quaternized polyaminena nogel a novel bile salt sequestering agent, ameliorates dyslipidmia through reduction of VLDL and LDL cholesterol, and induction of HDL cholesterol2011

    • Author(s)
      Rie Matsumori, Takashi Matsuzaka, Yukio Nagasaki, Hitoshi Shimano, et al
    • Organizer
      第43回日本動脈硬化学会学術集会
    • Place of Presentation
      ロイトン札幌、札幌
    • Year and Date
      2011-07-16
    • Related Report
      2011 Final Research Report
  • [Presentation] "PEGylated and quaternized polyamine nanogel" a novel bile salt sequestering agent, ameliorates dyslipidmia through reduction of VLDL and LDL cholesterol, and induction of HDL cholesterol2011

    • Author(s)
      Rie Matsumori, Takashi Matsuzaka, Yukio Nagasaki, Hitoshi Shimano, et al
    • Organizer
      第43回日本動脈硬化学会学術集会
    • Place of Presentation
      ロイトン札幌(札幌市)
    • Year and Date
      2011-07-16
    • Related Report
      2011 Annual Research Report
  • [Presentation] 動脈硬化戦略における脂質管理の新しい視点:臓器脂質の量的制御と質的制御2011

    • Author(s)
      島野仁
    • Organizer
      第54回日本糖尿病学会年次学術集会
    • Place of Presentation
      ロイトン札幌、札幌
    • Year and Date
      2011-05-20
    • Related Report
      2011 Final Research Report
  • [Presentation] 動脈硬化戦略における脂質管理の新しい視点:臓器脂質の量的制御と質的制御2011

    • Author(s)
      島野仁
    • Organizer
      第54回日本糖尿病学会年次学術集会
    • Place of Presentation
      ロイトン札幌(札幌市)(招待講演)
    • Year and Date
      2011-05-20
    • Related Report
      2011 Annual Research Report
  • [Presentation] 飢餓応答肝臓特異的転写因子CREBHの糖脂質代謝制御2011

    • Author(s)
      島野仁
    • Organizer
      第84回日本内分泌学会年次学術集会
    • Place of Presentation
      神戸国際会議場(神戸市)(招待講演)
    • Year and Date
      2011-04-21
    • Related Report
      2011 Annual Research Report
  • [Presentation] Anovel bile salt sequestering agent PEGylated and quaternized polyamine nanogel reduces VLDL and LDL cholesterol, raises HDL cholesterol, and prevents atherosclerosis in mice2011

    • Author(s)
      Haruna Shinozaki, Takashi Matsuzaka, Yukio Nagasaki, Hitoshi Shimano, et al
    • Organizer
      第34回日本分子生物学会年会
    • Place of Presentation
      パシフィコ横浜、横浜
    • Related Report
      2011 Final Research Report
  • [Presentation] A novel bile salt sequestering agent PEGylated and quaternized polyamine nanogel reduces VLDL and LDL cholesterol, raises HDL cholesterol, and prevents atherosclerosis in mice2011

    • Author(s)
      Haruna Shinozaki, Takashi Matsuzaka, Yukio Nagasaki, Hitoshi Shimano, et al
    • Organizer
      第34回日本分子生物学会年会
    • Place of Presentation
      パシフィコ横浜(横浜市)
    • Related Report
      2011 Annual Research Report
  • [Remarks]

    • URL

      http://www.u-tsukuba-endocrinology.jp/

    • Related Report
      2011 Final Research Report
  • [Remarks]

    • URL

      http://www.u-tsukuba-endocrinology.jp/

    • Related Report
      2011 Annual Research Report
  • [Patent(Industrial Property Rights)] 高分子化環状ニトロキシドラジカル化合物の経口投与用製剤2012

    • Inventor(s)
      長崎幸夫、吉冨徹、尾崎裕樹、ペナパーショパトンピクンラット、島野二、松坂賢、唐澤直義
    • Industrial Property Rights Holder
      筑波大学
    • Industrial Property Number
      2012-019975
    • Filing Date
      2012-01-13
    • Related Report
      2011 Annual Research Report

URL: 

Published: 2011-08-05   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi